Peerschke E I
Department of Pathology, State University of New York, Stony Brook 11794.
J Lab Clin Med. 1988 Jan;111(1):84-92.
Interactions between fibrinogen and human platelets leading to irreversible fibrinogen binding are poorly understood. Because fibrinogen possesses platelet recognition sites on both its alpha and gamma chains, the present study examined the hypothesis that irreversible platelet fibrinogen interactions occurred as a result of multivalent fibrinogen binding to platelet membrane glycoprotein IIb-IIIa complexes. Fibrinogen binding to human, gel-filtered platelets was assessed by using intact fibrinogen and a plasmic fibrinogen degradation product (8D-50) lacking intact alpha chains and resembling an intermediate fragment X. Irreversibly bound fibrinogen was defined as fibrinogen that remained associated with thrombin-stimulated platelets in the presence of 10 mmol/L ethylenediaminetetraacetic acid (EDTA) or excess unlabeled fibrinogen. The amount of intact fibrinogen that bound irreversibly to platelets comprised 54% +/- 12% (mean +/- SD, n = 8) of total binding. It was unaffected by fibrinogen receptor saturation and platelet alpha granule release. Similar amounts of 8D-50 (56% +/- 10%) bound irreversibly to platelets. Addition of 50 mumol/L arginine-glycine-asparagine-serine, after the initial binding of either fibrinogen or 8D-50, had no effect on the subsequent stabilization of platelet-fibrinogen or platelet-8D-50 interactions.(ABSTRACT TRUNCATED AT 250 WORDS)
纤维蛋白原与人类血小板之间导致不可逆纤维蛋白原结合的相互作用目前还了解甚少。由于纤维蛋白原在其α链和γ链上均具有血小板识别位点,本研究检验了这样一种假说,即不可逆的血小板-纤维蛋白原相互作用是由于多价纤维蛋白原与血小板膜糖蛋白IIb-IIIa复合物结合所致。通过使用完整的纤维蛋白原和一种缺乏完整α链且类似中间片段X的血浆纤维蛋白原降解产物(8D-50),评估纤维蛋白原与经凝胶过滤的人类血小板的结合情况。不可逆结合的纤维蛋白原被定义为在存在10 mmol/L乙二胺四乙酸(EDTA)或过量未标记纤维蛋白原的情况下仍与凝血酶刺激的血小板相关联的纤维蛋白原。不可逆结合到血小板上的完整纤维蛋白原的量占总结合量的54%±12%(平均值±标准差,n = 8)。它不受纤维蛋白原受体饱和度和血小板α颗粒释放的影响。相似量的8D-50(56%±10%)不可逆地结合到血小板上。在纤维蛋白原或8D-50初始结合后添加50 μmol/L的精氨酸-甘氨酸-天冬酰胺-丝氨酸,对随后血小板-纤维蛋白原或血小板-8D-50相互作用的稳定没有影响。(摘要截短于250字)